This section is intended for patients prescribed ADCETRIS. If you are a member of the public click here. If you are a UK healthcare professional click here.

Contact Us

How can we help you?

If you are a patient requiring advice or information on your medical condition or treatment please contact your doctor or visit the NHS Choices website in the first instance.

To contact the medical information department at Takeda UK Ltd, please use the form below.

Fields marked with an * are mandatory.

These details will only be used to help answer your question, and will never be used for promotional purposes.

Please read our website Privacy Policy before sending us any personal data via email.

Head Office

Building 3

Glory Park

Glory Park Avenue

Wooburn Green

Buckinghamshire

HP10 0DF

Phone +44 (0) 1628 537 900

Fax: +44 (0) 1628 526 615

Email: DSO-UK@takeda.com

ADCETRIS (brentuximab vedotin) is subject to additional monitoring. This will allow quick identification of new safety information.
You can help by reporting any side effects you may get. If you get any side effects whilst taking ADCETRIS, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed on this website or in the patient information leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine.

Takeda Oncology, Takeda logo and ADCETRIS are registered trademarks of Takeda Pharmaceutical Company Limited.

Other trademarks are the property of their respective owners.

© Takeda UK Limited, 2019

Registered office: Takeda UK Limited, Building 3, Glory Park, Glory Park Avenue, Wooburn Green, Bucks, HP10 0DF

Registered in England and Wales No. 3362860

UK/ADC/1707/0053h(1) - April 2019

Takeda Oncology logo